X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2020/11/09/2122659/0/en/Kitov-Expands-Planned-Phase-1-2-Clinical-Trial-of-CM24-in-Non-Small-Cell-Lung-Cancer-with-New-Cohort-to-Evaluate-CM24-in-Patients-with-Pancreatic-Cancer-Conducted-with-Bristol-Myer.html
https://www.globenewswire.com/news-release/2020/07/09/2059866/0/en/Kitov-Announces-Initiation-of-Phase-1-2-Clinical-Trial-of-NT219-in-Advanced-Cancer-Patients.html
https://www.globenewswire.com/news-release/2020/07/08/2059185/0/en/kitov-pharma-receives-notice-of-intention-to-grant-a-european-patent-covering-cm24-its-anti-ceacam1-antibody.html
https://www.globenewswire.com/news-release/2020/07/02/2056925/0/en/Kitov-Pharma-Issues-CEO-Shareholder-Letter-Providing-Business-Update.html
https://www.globenewswire.com/news-release/2020/05/22/2037517/0/en/Kitov-Announces-U-S-FDA-Acceptance-of-Investigational-New-Drug-Application-to-Conduct-Phase-1-2-Clinical-Trial-of-NT219-in-Multiple-Types-of-Advanced-Cancer-Patients.html
https://finance.yahoo.com/news/kitov-pharma-ltd-announces-cash-120510763.html
https://www.globenewswire.com/news-release/2020/02/24/1989293/0/en/Kitov-Pharma-Expands-Planned-NT-219-Clinical-Program-for-Difficult-to-Treat-Cancers.html
Market Place
Share 
